Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,958 public trials 2,018 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Adjuvant Low Dose Total Body Irradiation in Elderly Patients With Diffuse Large B-Cell Lymphoma

NCT00834951

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Not specified

View Trial Details

Completed

Stem Cell Transplantation for Patients With Hematologic Malignancies

NCT00152139

Conditions: Acute Lymphoblastic Leukemias, Acute Myelocytic Leukemia, Anemia, +31 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Completed

Haploidentical Stem Cell Transplantation for Patients With Hematologic Malignancies

NCT00186823

Conditions: Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +35 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Completed

Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies

NCT00143559

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Anemia, +34 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Completed

The Optimal Timing of a Second Autologous Peripheral Blood Stem Cell Transplantation in Patients (<61 Years) With Multiple Myeloma

NCT00207805

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Centre National de Greffe de Moelle Osseuse Tunis, Tunisia

View Trial Details

Completed

Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy in Adults With Hematopoietic Disorders Undergoing MUD SCT

NCT00516152

Conditions: Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Advanced Myeloproliferative Disease, +41 more
Locations: University of California San Francisco San Francisco, California, United States

View Trial Details

Completed

Arsenic Trioxide and Thalidomide in the Treatment of Refractory Multiple Myeloma

NCT00193544

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Not specified

View Trial Details

Completed

Behavioral Intervention For BMT/SCT Survivors

NCT00579917

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +19 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Feasibility of Risk-Adapted Therapy in Young Adult Acute Lymphoblastic Leukemia: a Multicenter Trial

NCT00222027

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Service d'Hématologie Clinique, Hôpital Purpan Toulouse, France

View Trial Details

Completed

STA-5312 Administered on Alternate Weekdays Every Two Weeks to Patients With Hematologic Malignancies and Patients With Solid Tumors

NCT00088101

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hematological Malignancies, +15 more
Locations: Wilshire Oncology Medical Group Pomona, California, United States

Baptist Cancer Institute Jacksonville, Florida, United States

University of Chicago Chicago, Illinois, United States

Tufts New England Medical Center Boston, Massachusetts, United States

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions